Report Overview

The global nebulizer market was pegged at US$ 1.05 billion in 2021 and is expected to witness a CAGR of 6.5% during the forecast period. 

Market Fundamentals 

Nebulizer is a drug delivery device that converts the medication from a liquid to a mist for its inhalation into the lungs.  It transforms liquids and suspensions into tiny aerosol droplets that can be inhaled through a mask or the device's mouthpiece, using oxygen, compressed air, or ultrasonic energy. It is designed to treat asthma, COPD, cystic fibrosis, and other respiratory disorders.

Nebulizers are manufactured in both electric or battery-run versions and either of them can be portable or tabletop. Common components for both versions of the nebulizer are the base that holds the air compressor, a medicine vial, and a tube connecting the vial to the compressor.

[4564563]

Market Dynamics

The global nebulizer market is mainly driven by the high prevalence of respiratory diseases namely asthma, cystic fibrosis, and chronic obstructive pulmonary disease, which in turn is attributed to many factors like increasing environmental pollution, alcohol consumption, and tobacco intake. The increasing geriatric population is also driving the market. The covid-19 pandemic has positively affected the market. Other factors such as an increase in the number of smokers, improved healthcare infrastructure, portability, and cost-effectiveness of these devices are pushing the market towards growth. 

However, the spraying technique of the nebulizer leads to wastage of medicine which has turned out to be a major challenge for the market. This has led to the emergence and wider presence of nebulizer substitutes such as inhalers.

Market Ecosystem

The global nebulizer market has been analyzed from six perspectives: product type, application, usage, portability, end user, and region. 

Nebulizer Market by Product Type

[34324234]

Based on product type, the market has been segmented into the pneumatic, mesh, and ultrasonic type nebulizers. The pneumatic nebulizers segment is expected to hold the highest market share during the forecast period due to its low cost. Also, these nebulizers are more effective in drug delivery than other dry powder inhalers and pressurized meter dose inhalers. The ease of handling and efficient design for medication delivery makes it the prime segment in the market, over the years. 

Nebulizer Market by Application 

Based on application, the market has been segmented into asthma, COPD, cystic fibrosis, and other respiratory diseases. The growing prevalence of chronic obstructive pulmonary disease or COPD has proved to be a booster for the use of nebulizer devices globally. Elevated concentration of pollutants in the environment, tobacco smoking, long term exposure to occupational fumes and gases attributes to the risk of COPD, which in turn is raising the usage of nebulizers in the affected patients. 

Nebulizer Market by Usage

Based on usage, the market has been segmented into disposable and reusable nebulizers. The reusable nebulizers are expected to push the market due to their feature of multiple usages as compared to disposable nebulizers. 

Nebulizer Market by Portability

Based on portability, the market has been segmented into portable and tabletop nebulizers. The tabletop nebulizers because of their operational benefits and the presence of the large number of players manufacturing tabletop nebulizers, have attributed to their high market share in the market. 

Nebulizer Market by End User

Hospitals and clinics, home healthcare, and emergency services are the key end-users of nebulizers. The increased aging population and growing need for avoiding unnecessary hospital admissions have raised the demand for home healthcare devices, in turn augmenting the growth of home healthcare segment. This segment is also expected to dominate the global nebulizer market with the highest revenue and volume share during the forecast period. 

Nebulizer Market by Region

Based on region, the global nebulizer market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America dominates the global nebulizer market due to the better adoption of technology and the resultant launch of new products  Higher incidence of Asthma and COPD  are expected to contribute to the dominance of North America’s nebulizer market during the forecast period. However, the Asia-Pacific nebulizer market is expected to grow significantly in the coming years because of the increase in the elderly population and the growing attention on preventive care. 

Competitive Landscape

Some of the prominent players operating in the global nebulizer market are GE Healthcare Inc., Briggs Healthcare, Allied Healthcare Products, Inc., PARI Pharma GmbH, Omron Corporation, Teleflex Incorporated, Koninklijke Philips N.V., Aerogen, Beurer GmBH, and BD & Company among others. 

Strategic Developments

• October 2020, Aerogen signed an agreement with Synairgen plc, a Southampton, UK-based biotechnology company, to provide the market-leading Aerogen® Solo/Ultra nebulizer system for delivery of SNG001 directly into the lungs of COVID-19 patients. SNG001 is an inhaled interferon beta that stimulates the innate immune system. Initial investigation of SNG001 as a potential COVID-19 treatment. 
• June 2020, Respira Technologies, Inc., announced the launch of the pharmaceutical-focused commercial development program for the RespiRxTM drug delivery device platform. The RespiRxTM is the first orientation agnostic vibrating mesh nebulizer (VMN) device that effectively operates portably and, in any position, held by the patient.
• November’2019, Omron Healthcare announced its collaboration with AstraZeneca for joint research and development to deliver various therapeutic services. One such instance is the establishment of pediatric nebulization rooms for the treatment of acute asthma in China. 

Frequently Asked Questions About This Report